Loading...
Braskem S.A.
BAK•NYSE
Basic MaterialsChemicals
$3.69
$0.01(0.41%)
Braskem S.A. (BAK) Financial Performance & Statements
Review Braskem S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
9.70%
↑ 9.70%
Operating Income Growth
36.39%
↑ 36.39%
Net Income Growth
-147.22%
↓ 147.22%
Operating Cash Flow Growth
207.17%
↑ 207.17%
Operating Margin
-2.13%
↓ 2.13%
Gross Margin
7.75%
↑ 7.75%
Net Profit Margin
-14.62%
↓ 14.62%
ROE
2762.42%
↑ 2762.42%
ROIC
-2.25%
↓ 2.25%
Braskem S.A. (BAK) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Braskem S.A. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $19.15B | $21.27B | $19.07B | $17.92B |
| Cost of Revenue | $18.005B | $19.02B | $17.68B | $16.71B |
| Gross Profit | $1.15B | $2.25B | $1.39B | $1.21B |
| Gross Profit Ratio | $0.06 | $0.11 | $0.07 | $0.07 |
| R&D Expenses | $143.00M | $109.00M | $106.00M | $106.00M |
| SG&A Expenses | $1.31B | $1.17B | $936.00M | $1.16B |
| Operating Expenses | $3.57B | $1.23B | $1.46B | $1.30B |
| Total Costs & Expenses | $21.57B | $20.25B | $19.14B | $18.008B |
| Interest Income | $302.00M | $366.00M | $141.00M | $363.00M |
| Interest Expense | $1.93B | $1.10B | $1.47B | $1.06B |
| Depreciation & Amortization | $1.14B | $1.29B | $1.29B | $1.23B |
| EBITDA | -$5.26B | $1.08B | -$3.24B | $336.00M |
| EBITDA Ratio | -$0.27 | $0.05 | -$0.17 | $0.02 |
| Operating Income | -$2.42B | $1.02B | -$158.00M | -$88.00M |
| Operating Income Ratio | -$0.13 | $0.05 | -$0.008 | -$0.005 |
| Other Income/Expenses (Net) | -$5.91B | -$2.33B | -$5.84B | -$2.02B |
| Income Before Tax | -$8.33B | -$1.31B | -$6.00B | -$2.07B |
| Income Before Tax Ratio | -$0.43 | -$0.06 | -$0.31 | -$0.12 |
| Income Tax Expense | -$2.44B | -$444.00M | -$2.11B | -$681.00M |
| Net Income | -$5.65B | -$593.00M | -$3.73B | -$1.34B |
| Net Income Ratio | -$0.29 | -$0.03 | -$0.20 | -$0.08 |
| EPS | -$7.08 | -$0.74 | -$4.69 | -$1.69 |
| Diluted EPS | -$7.08 | -$0.74 | -$4.69 | -$1.69 |
| Weighted Avg Shares Outstanding | $796.97M | $796.97M | $797.21M | $797.21M |
| Weighted Avg Shares Outstanding (Diluted) | $796.97M | $796.97M | $797.21M | $797.21M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan